Roche and Galapagos expand COPD alliance
This article was originally published in Scrip
Executive Summary
Galapagos has expanded its global multi-year strategic alliance with Roche that was signed at the start of the year to develop potential new therapies in chronic obstructive pulmonary disease (COPD).